Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Respiratory Syncytial Virus Prevention: A New Era of Vaccines
2023
· Jiangsu University,
· University of Massachusetts,
· Mayo Clinic,
· Johns Hopkins University,
· Rochester Regional Health,
· Mir Neurology
This editorial discusses new vaccines for preventing respiratory syncytial virus (RSV) infections. RSV affects the lungs and can be serious, especially in young children and …
Ask aRCie
Cost-Effectiveness Analysis of Nirsevimab and Maternal Rsvpref Vaccine Strategies for Prevention of Respiratory Syncytial Virus Disease Among Infants in Canada: A Simulation Study
2023
· Yale University,
· York University,
· Dalhousie University
This study in Canada assessed cost-effectiveness of nirsevimab and RSVpreF for preventing RSV in infants. Modeling different interventions showed immunizing the birth cohort with nirsevimab …
Preventing Respiratory Syncytial Virus in Children in France: A Narrative Review of the Importance of a Reinforced Partnership Between Parents, Healthcare Professionals, and Public Health Authorities
This article describes the importance of preventing respiratory syncytial virus (RSV) in young children in France. It highlights the need for a strong partnership between …
The Efficacy and Safety of Nirsevimab for the Prevention of RSV Infection Among Infants: A Systematic Review and Meta-Analysis
This article describes a study on nirsevimab, a new drug to prevent RSV infections in infants. RSV is a virus that can cause serious lung …
The Rapidly Changing Landscape of Respiratory Syncytial Virus Prophylaxis
2023
· University of Alberta,
· McGill University
The article describes the changing ways to prevent respiratory syncytial virus (RSV) in Canada. New methods include a monoclonal antibody called nirsevimab and vaccines for …
Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands
2023
· National Institute for Public Health and the Environment,
· University Medical Center Utrecht,
· Wilhelmina Children's Hospital
This article describes a study about using palivizumab to prevent RSV infections. It focuses on very preterm infants during their first year. The research took …
Formulary Drug Reviews: Nirsevimab
2024
· Washington State University
This article discusses the Formulary Drug Reviews on nirsevimab, a monoclonal antibody for preventing respiratory syncytial virus (RSV) in newborns and infants. It covers the …
Safety and Efficacy of Nirsevimab in a Universal Prevention Program of Respiratory Syncytial Virus Bronchiolitis in Newborns and Infants in the First Year of Life in the Valle d'Aosta Region, Italy, in the 2023-2024 Epidemic Season
This article describes a study on the safety and effectiveness of nirsevimab, a monoclonal antibody, in preventing RSV bronchiolitis in newborns and infants during the …
Impact of Nirsevimab Immunization on Pediatric Hospitalization Rates: A Systematic Review and Meta-Analysis (2024)
2024
· Servizio di Prevenzione e Sicurezza Negli Ambienti di Lavoro (SPSAL),
· University of Palermo,
· APSS Trento,
· University of Parma,
· Turin Local Health Authority
This article reviews the effects of nirsevimab immunization on reducing hospital visits for children. It describes how researchers looked at different studies to see if …
Game Over for RSV?
2023
· Yale University
This letter comments on a study by D. Wilkins and colleagues and concludes that passive immunization with nirsevimab protects infants from severe respiratory syncytial virus …